INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders – RP, CUB, CRHM, OXFD, FLIR, CBLI, AJRD

NEW YORK, Feb. 17, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RealPage, Inc. (NASDAQ: RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $88.75 in cash per share. If you are a RealPage shareholder, click here to learn more about your rights and options.  

Cubic Corporation (NYSE: CUB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Veritas Capital and Evergreen Coast Capital Corporation. Under the terms of the merger agreement, Cubic shareholders will receive $70.00 per share in cash. If you are a Cubic shareholder, click here to learn more about your rights and options.  

CRH Medical Corporation (NYSE: CRHM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Well Health Technologies Corp. for $4.00 per share. If you are a CRH Medical shareholder, click here to learn more about your rights and options.  

Oxford Immunotec Global PLC (NASDAQ: OXFD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to PerkinElmer, Inc. for $22.00 in cash per share. If you are an Oxford shareholder, click here to learn more about your rights and options.

FLIR Systems, Inc. (NASDAQ: FLIR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Teledyne Technologies Incorporated for $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share. If you are a FLIR shareholder, click here to learn more about your rights and options.

Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company. If you are a Cleveland BioLabs shareholder, click here to learn more about your rights and options. 

Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Lockheed Martin Corporation for $56.00 per share in cash. As part of the transaction, Aerojet declared a $5.00 per share pre-closing special dividend to certain holders of its common shares and convertible senior notes which, unless revoked, will adjust the consideration to be paid by Lockheed to $51.00 per share at closing. If you are an Aerojet shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLPDaniel Sadeh, Esq. Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com 
zhalper@halpersadeh.com  
https://www.halpersadeh.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-investigates-the-following-companies-on-behalf-of-shareholders–rp-cub-crhm-oxfd-flir-cbli-ajrd-301230183.html

SOURCE Halper Sadeh LLP